Resources from the same session
Welcome and Introduction
Presenter: Benjamin Besse
Session: AbbVie Inc. - Targeting un-MET Needs in Cancer: The Emerging Role of Antibody-Drug Conjugates (ADCs)
Resources:
Webcast
History of c-Met: Lessons Learned
Presenter: Benjamin Besse
Session: AbbVie Inc. - Targeting un-MET Needs in Cancer: The Emerging Role of Antibody-Drug Conjugates (ADCs)
Resources:
Webcast
Rethinking c-Met as a Therapeutic Target in Non-Small Cell Lung Cancer (NSCLC)
Presenter: Antonio Passaro
Session: AbbVie Inc. - Targeting un-MET Needs in Cancer: The Emerging Role of Antibody-Drug Conjugates (ADCs)
Resources:
Webcast
Rethinking c-Met as a Therapeutic Target in Gastrointestinal Cancers (GI)
Presenter: John Strickler
Session: AbbVie Inc. - Targeting un-MET Needs in Cancer: The Emerging Role of Antibody-Drug Conjugates (ADCs)
Resources:
Webcast
Emerging Evidence on c-Met Targeting in GI
Presenter: Eric Van Cutsem
Session: AbbVie Inc. - Targeting un-MET Needs in Cancer: The Emerging Role of Antibody-Drug Conjugates (ADCs)
Resources:
Webcast
Panel Discussion, Q&A, and Closing
Presenter: Benjamin Besse, Antonio Passaro, Nicolas Girard, John Strickler, Eric Van Cutsem
Session: AbbVie Inc. - Targeting un-MET Needs in Cancer: The Emerging Role of Antibody-Drug Conjugates (ADCs)
Resources:
Webcast
Closing
Presenter: Benjamin Besse
Session: AbbVie Inc. - Targeting un-MET Needs in Cancer: The Emerging Role of Antibody-Drug Conjugates (ADCs)
Resources:
Webcast